Edge
StocktwitsEarnings

Official STOCKTWITS Representative

$BDSX Q2 '26 Earnings Results & Recap
• Reported GAAP EPS of -$0.71 up 55.62% YoY
• Reported revenue of $26.86M up 34.18% YoY
• Biodesix expects total revenue of $108-114 million for full year 2026, with the midpoint representing approximately 25% growth over 2025, and maintains gross margin guidance of approximately 80% for 2026.Price since post
Advertisement|Remove ads.